Cymoplive is focused on transforming how cancer therapies are evaluated.
We develop technologies that reveal how aggressive cancer cells move and adapt within environments that mirror human disease progression.
Our platform delivers insights to identify therapies capable of limiting metastasis, resistance, and relapse - while reducing the risk of costly late-stage animal or clinical trial failures. 

Our goal is to simply enable better therapeutic decisions so more patients receive durable treatments and improved quality of life.

Cymoplive

Org chart

Teams

Offices